Mary Alvarez-Nutting, NP
Nurse Practitioner · Oakland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Roots Community Health Center · 14 clinicians in this group
Hospitals listed: Highland Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Mary Alvarez-Nutting’s office at (510) 777-1177 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Highland HospitalOakland, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Alameda Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 1 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.568, Oct 2024 – Sep 2025
See every measure and the patient survey for Highland Hospital
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 5 the same, 1 worse of 6 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.568 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 487 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.7 to 1.42) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 198.35 (145.43 to 251.26) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 83 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 68 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 1,143 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 4,370 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,344 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.54 (0.29 to 4.79) · 689 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.37 to 3.78) · 165 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.91 (0.34 to 3.48) · 681 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.62 (2.72 to 20.53) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.44 (1.37 to 9.5) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.97 (0.49 to 3.45) · 126 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.76 (0.07 to 1.44) · 3,387 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.519 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.682 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 51 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 184 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 141.8 · 59 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 27.6 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 35.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 243 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.2 to 7.7) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.5 (9.7 to 18.5) · 64 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 19.4) · 355 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,960 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
Original Medicare doctor bills
$2,137
Medicare paid this office $2,137 for 24 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
24 Original Medicare patients in 2024. Average age 64 · Under 65 46% · Women 46% · Also on Medicaid 100% · Health risk score 1.50. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 54%.
The office billed $3,396, Medicare allowed $2,947 and paid $2,137; for 33 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 24 | 33 | 64 | 1.50 | $3,396 | $2,137 |
| 2023 | 30 | 96 | 61 | 0.94 | $11,025 | $6,251 |
| 2022 | 22 | 80 | 59 | 1.25 | $10,399 | $5,832 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 11 | $2,542 | $102 |
| Short return visit (20+ min) | 20 | $2,402 | $60 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 12 | $422 | $18 |
2022: 2 services
| Short return visit (20+ min) | 16 | $2,816 | $61 |
| Return visit (30+ min) | 13 | $1,785 | $89 |
Medicaid work
$4,506 in 2024
Medicaid paid $4,506 for 218 billed services this clinician did in 2024, up to 34 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 138 | $2,318 |
| Short return visit | 80 | $2,188 |
| 2024 | 218 | 2 | 34 | $4,506 |
| 2023 | 262 | 2 | 21 | $234 |
| 2022 | 437 | 2 | 30 | $52 |
| 2021 | 173 | 3 | 22 | $91 |
| 2020 | 154 | 2 | 24 | $102 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 99 | $173 |
| Short return visit (20+ min) | 163 | $61 |
2022
| Return visit (30+ min) | 117 | $28 |
| Short return visit (20+ min) | 320 | $24 |
2021
| Short return visit (20+ min) | 99 | $91 |
| Blood glucose (sugar) level | 15 | $0 |
| Return visit (30+ min) | 59 | $0 |
2020
| Short return visit (20+ min) | 122 | $71 |
| Return visit (30+ min) | 32 | $32 |
Drugs they prescribed that Part D paid
$27,972
Pharmacies billed $27,972 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
135 generic and 32 brand-name prescriptions · $27,972 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 11 | $304 | $28 |
Year by year
| 2024 | 167 | 46 | None | 19% | $27,972 |
| 2023 | 106 | 28 | None | None | $5,365 |
| 2022 | 156 | 31 | None | 9% | $5,699 |
| 2021 | 147 | 23 | None | 13% | $9,082 |
| 2020 | 174 | 18 | 0% (0) | 21% | $15,279 |
| 2019 | 107 | 17 | None | None | $9,964 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Metoprolol | 11 | $190 | $17 |
2022: 3 drugs
| Atorvastatin | 26 | $486 | $19 |
| Amlodipine Besylate | 14 | $36 | $3 |
| Hydrochlorothiazide | 12 | $26 | $2 |
2021: 3 drugs
| Atorvastatin | 23 | $182 | $8 |
| Metoprolol | 19 | $111 | $6 |
| Amlodipine Besylate | 13 | $62 | $5 |
2020: 2 drugs
| Atorvastatin | 17 | $125 | $7 |
| Ibuprofen | 12 | $81 | $7 |
2019: 1 drug
| Ventolin Hfa | 11 | $641 | $58 |
Money from drug and device companies
$258 in 2025
| 2025 | 5 | 6 | None | $258 |
| 2024 | 3 | 5 | None | $220 |
| 2023 | 3 | 5 | None | $117 |
| 2022 | 1 | 1 | None | $26 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Lilly USA | Zepbound | $122 | 1 payment
|
| Abbvie | Mavyret | $51 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $36 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $30 | 1 payment
|
| ViiV Healthcare | Apretude | $20 | 1 payment
|
See all 6 published payments
| Abbvie | Meals · 2025-10-27 | Mavyret | $19 |
| Lilly USA | Meals · 2025-10-22 | Zepbound | $122 |
| Abbvie | Meals · 2025-10-10 | Mavyret | $32 |
| Exact Sciences | Meals · 2025-10-09 | Cologuard Collection Kit | $30 |
| Dexcom | Meals · 2025-04-18 | Dexcom G6 Transmitter | $36 |
| ViiV Healthcare | Meals · 2025-03-28 | Apretude | $20 |
See earlier years (2024, 2023, 2022)
2024: $220
| Bayer Healthcare Pharmaceuticals | Kerendia | $121 | 1 payment
|
| Indivior | Sublocade | $76 | 3 payments
|
| Pfizer | Prevnar 20 | $22 | 1 payment
|
2023: $117
| Indivior | Sublocade | $45 | 2 payments
|
| Dexcom | Dexcom G6 Transmitter | $45 | 2 payments
|
| Pfizer | Prevnar 20 | $27 | 1 payment
|
2022: $26
| Abbvie | Mavyret | $26 | 1 payment
|
Professional record
- NPI
- 1447732409
- Licence
- CA 8003962210, CA 95010112
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 1223D0004X (1223D0004X)
- Mailing address
- 3826 38th Ave, Oakland, CA, 94619
- NPI first listed
- 2018-09-05
- NPI last updated
- 2019-07-08
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1998 Alum Rock Ave, San Jose, CA, 95116